ERBB2 and breast carcinoma: HER2-specific magnetic nanoparticles can carry and release coloaded chemotherapeutic drugs both in vitro and in vivo [26] and have been successfully used to inhibit the proliferation of breast cancer cells [82–84] and in primary systemic therapy prior to surgical intervention [85].